GILEAD SCIENCES, INC. Accumulated OCI 2008-2026 | GILD
Beta
What is accumulated oci?
Accumulated other comprehensive income (OCI) includes unrealized gains and losses from foreign currency translation, available-for-sale securities, and pension adjustments.
What is GILEAD SCIENCES, INC.'s current accumulated oci?
GILEAD SCIENCES, INC. (GILD) annual accumulated oci for 2025 was $39.0M, a 70.45% decline from 2024. GILEAD SCIENCES, INC. accumulated oci for the quarter ending March 31, 2026 was $78.0M.
What was GILEAD SCIENCES, INC.'s accumulated oci in 2024?
GILEAD SCIENCES, INC. annual accumulated oci for 2024 was $132.0M, a 371.43% increase from 2023.
What was GILEAD SCIENCES, INC.'s accumulated oci in 2023?
GILEAD SCIENCES, INC. annual accumulated oci for 2023 was $28.0M, a 1300.00% increase from 2022.
Accumulated OCI History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-60.0M
→
FY2025
$39.0M
080910111213141516171819202122232425
5 years selected
Accumulated OCI History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $39.0M | -70.5% | 10-K |
| FY2024 | $132.0M | +371.4% | 10-K |
| FY2023 | $28.0M | +1300.0% | 10-K |
| FY2022 | $2.0M | -97.6% | 10-K |
| FY2021 | $83.0M | +238.3% | 10-K |
| FY2020 | $-60.0M | -170.6% | 10-K |
| FY2019 | $85.0M | +6.3% | 10-K |
| FY2018 | $80.0M | -51.5% | 10-K |
| FY2017 | $165.0M | -40.6% | 10-K |
| FY2016 | $278.0M | +215.9% | 10-K |
| FY2015 | $88.0M | -70.8% | 10-K |
| FY2014 | $301.0M | +342.7% | 10-K |
| FY2013 | $-124.0M | -169.6% | 10-K |
| FY2012 | $-46.0M | -179.0% | 10-K |
| FY2011 | $58.2M | +88.3% | 10-K |
| FY2010 | $30.9M | +636.8% | 10-K |
| FY2009 | $-5.8M | -114.0% | 10-K |
| FY2008 | $41.2M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →